SPECTRUM PHARMACEUTICALS INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Operating Lease, Payments for the quarter ending March 31, 2023 was $208K, a 64.4% decline year-over-year.
  • Spectrum Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $1.69M, a 20% decline from 2021.
  • Spectrum Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $2.12M, a 11.9% decline from 2020.
  • Spectrum Pharmaceuticals Inc annual Operating Lease, Payments for 2020 was $2.4M, a 30.8% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $208K -$376K -64.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $584K -$36K -5.81% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $620K +$27K +4.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $593K +$122K +25.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $471K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.